Founders of healthcare startups have the potential to bring new life-changing technology to patients, but must navigate a complex landscape of prototyping, partnerships, funding and regulation. Hear from founders and investors in the healthcare space on how they have improved the outcomes for their businesses. The panel will discuss trends in growth and funding in the ecosystem.

Moderator

Kyle Myers Independent Consultant

Kyle Myers recently retired as Director and Senor Advisor in the Division of Imaging, Diagnostics, and Software Reliability at the US Food and Drug Administration's Center for Devices and Radiological Health. Her division specialized in evaluating the safety and effectiveness of new healthcare devices being brought to market in the US. Dr. Myers earned her PhD in Optical Sciences from the Univ. of Arizona College of Optical Science. She is an independent consultant and resides in Phoenix, Arizona.

Panelists

Neil P. Ray CEO and Founder Raydiant Oximetry (United States)

Dr. Neil P. Ray is the CEO and Founder of Raydiant Oximetry - a medical device company in the women's health care space. Raydiant Oximetry has developed a non-invasive fetal oximeter to improve outcomes for mothers and babies during childbirth. Dr. Ray is a board-certified pediatric anesthesiologist and served as PI (principal investigator) for several NIH and NSF awards.

Rachel Kuperman CEO and founder Eysz (United States)

Dr. Rachel Kuperman is the CEO and founder of Eysz, which is developing a digital health platform using passive eye-movements as input to measure, diagnose, and predict neurological disease starting with epilepsy. Prior to founding Eysz, she was Medical Director at UCSF Benioff Children's Hospital, Oakland, where she developed the epilepsy program by focusing on excellence in clinical care, and research.

Jay Reddy CEO and Founder Advanced Optronics (United States)

Dr. Jay Reddy is founder of Advanced Optronics. Advanced Optronics is focused on developing flexible, biocompatible intraoperative sensors to reduce surgical trauma during Cochlear implantation. Previously, he completed his Ph.D. at Carnegie Mellon University developing optical brain-computer interfaces in flexible polymer material platforms.

Bill Hyun Venture Partner Genoa Ventures (United States)

Dr. Bill Hyun has demonstrated the ability to identify disruptive science applied to biotechnology opportunities in transformative markets. He is a Venture Partner at Genoa Ventures, investing at the intersection of biology and technology. He also directs the Laboratory for Advanced Cytometry at the University of California, San Francisco (UCSF).